Metabolic Stack
Targeted fat loss without muscle sacrifice
OVERVIEW
A precision fat-loss protocol combining AOD-9604's selective lipolytic action with CJC-1295 and Ipamorelin's growth hormone pulse. AOD-9604 targets adipose tissue via β3 adrenergic receptors without affecting IGF-1 or blood glucose. CJC-1295 + Ipamorelin amplify the overnight GH pulse to enhance fat oxidation and preserve lean mass. Caloric deficit required.
COMPOUNDS
What's in this stack
Selective lipolysis — β3 adrenergic receptor activation in adipose tissue
AOD-9604 is a stabilised peptide fragment of human growth hormone (amino acids 177–191) specifically isolated for its li…
GHRH analogue — amplifies overnight GH pulse for fat oxidation
CJC-1295 (with DAC) is a modified GHRH analogue with a Drug Affinity Complex that extends its half-life from minutes to …
Selective GH secretagogue — no cortisol or prolactin spike
Ipamorelin is a third-generation GHRP (growth hormone releasing peptide) and the most selective GH secretagogue availabl…
ORDER
OTHER STACKS
For research and laboratory use only. Not intended for human consumption.